BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Analyst Ratings
USA - NASDAQ:BDRX - US59564R8806 - ADR
6.61 USD
+0.09 (+1.38%)
ChartMill assigns a Buy % Consensus number of 86% to BDRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 183.6. This target is 2677.61% above the current price.
BDRX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BDRX.
In the previous month the buy percentage consensus was at a similar level.
BDRX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-08 | Ladenburg Thalmann | Initiate | Buy |